|
1
|
Gan J, Mao XR, Zheng SJ and Li JF:
Invariant natural killer T cells: Not to be ignored in liver
disease. J Dig Dis. 22:136–142. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Yan Y, Zeng J, Xing L and Li C: Extra- and
intra-cellular mechanisms of hepatic stellate cell activation.
Biomedicines. 9:10142021. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Highton AJ, Schuster IS, Degli-Esposti MA
and Altfeld M: The role of natural killer cells in liver
inflammation. Semin Immunopathol. 43:519–533. 2021. View Article : Google Scholar
|
|
4
|
St-Pierre F, Bhatia S and Chandra S:
Harnessing natural killer cells in cancer immunotherapy: A review
of mechanisms and novel therapies. Cancers (Basel). 13:19882021.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Zheng M, Sun H and Tian Z: Natural killer
cells in liver diseases. Front Med. 12:269–279. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Gao B, Radaeva S and Jeong WI: Activation
of natural killer cells inhibits liver fibrosis: A novel strategy
to treat liver fibrosis. Expert Rev Gastroenterol Hepatol.
1:173–180. 2007. View Article : Google Scholar
|
|
7
|
Schuppan D, Ashfaq-Khan M, Yang AT and Kim
YO: Liver fibrosis: Direct antifibrotic agents and targeted
therapies. Matrix Biol. 68-69:435–451. 2018. View Article : Google Scholar
|
|
8
|
Jeong WI, Park O, Suh YG, Byun JS, Park
SY, Choi E, Kim JK, Ko H, Wang H, Miller AM and Gao B: Suppression
of innate immunity (natural killer cell/interferon-gamma) in the
advanced stages of liver fibrosis in mice. Hepatology.
53:1342–1351. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Roehlen N, Crouchet E and Baumert TF:
Liver fibrosis: Mechanistic concepts and therapeutic perspectives.
Cells. 9:8752020. View Article : Google Scholar
|
|
10
|
Wree A, McGeough MD, Inzaugarat ME, Eguchi
A, Schuster S, Johnson CD, Peña CA, Geisler LJ, Papouchado BG,
Hoffman HM and Feldstein AE: NLRP3 inflammasome driven liver injury
and fibrosis: Roles of IL-17 and TNF in mice. Hepatology.
67:736–749. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wan M, Han J, Ding L, Hu F and Gao P:
Novel immune subsets and related cytokines: Emerging players in the
progression of liver fibrosis. Front Med. 8:6048942021. View Article : Google Scholar
|
|
12
|
Jiang JX, Mikami K, Venugopal S, Li Y and
Török NJ: Apoptotic body engulfment by hepatic stellate cells
promotes their survival by the JAK/STAT and Akt/NF-kappaB-dependent
pathways. J Hepatol. 51:139–148. 2009. View Article : Google Scholar
|
|
13
|
Tanwar S, Rhodes F, Srivastava A,
Trembling PM and Rosenberg WM: Inflammation and fibrosis in chronic
liver diseases including non-alcoholic fatty liver disease and
hepatitis C. World J Gastroenterol. 26:109–133. 2020. View Article : Google Scholar
|
|
14
|
Luo DZ, Vermijlen D, Ahishali B, Triantis
V, Plakoutsi G, Braet F, Vanderkerken K and Wisse E: On the cell
biology of pit cells, the liver-specific NK cells. World J
Gastroenterol. 6:1–11. 2000. View Article : Google Scholar
|
|
15
|
Wisse E, van't Noordende JM, van der
Meulen J and Daems WT: The pit cell: Description of a new type of
cell occurring in rat liver sinusoids and peripheral blood. Cell
Tissue Res. 173:423–435. 1976. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Tang L, Peng H, Zhou J, Chen Y, Wei H, Sun
R, Yokoyama WM and Tian Z: Differential phenotypic and functional
properties of liver-resident NK cells and mucosal ILC1s. J
Autoimmun. 67:29–35. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wang Y and Zhang C: The Roles of
Liver-resident lymphocytes in liver diseases. Front Immunol.
10:15822019. View Article : Google Scholar
|
|
18
|
Lunemann S, Martrus G, Goebels H, Kautz T,
Langeneckert A, Salzberger W, Koch M, J Bunders M, Nashan B, van
Gisbergen KPJM and Altfeld M: Hobit expression by a subset of human
liver-resident CD56bright Natural Killer cells. Sci Rep.
7:66762017. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Hudspeth K, Donadon M, Cimino M, Pontarini
E, Tentorio P, Preti M, Hong M, Bertoletti A, Bicciato S,
Invernizzi P, et al: Human liver-resident CD56(bright)/CD16(neg) NK
cells are retained within hepatic sinusoids via the engagement of
CCR5 and CXCR6 pathways. J Autoimmun. 66:40–50. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhang C, Hu Y, Xiao W and Tian Z: Chimeric
antigen receptor- and natural killer cell receptor-engineered
innate killer cells in cancer immunotherapy. Cell Mol Immunol.
18:2083–2100. 2021. View Article : Google Scholar
|
|
21
|
Obajdin J, Davies DM and Maher J:
Engineering of chimeric natural killer cell receptors to develop
precision adoptive immunotherapies for cancer. Clin Exp Immunol.
202:11–27. 2020. View Article : Google Scholar
|
|
22
|
Vrazo AC, Hontz AE, Figueira SK, Butler
BL, Ferrell JM, Binkowski BF, Li J and Risma KA: Live cell
evaluation of granzyme delivery and death receptor signaling in
tumor cells targeted by human natural killer cells. Blood.
126:e1–e10. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Saparbay J, Tanaka Y, Tanimine N, Ohira M
and Ohdan H: Everolimus enhances TRAIL-mediated anti-tumor activity
of liver resident natural killer cells in mice. Transpl Int.
33:229–243. 2020. View Article : Google Scholar
|
|
24
|
Choi WM, Ryu T, Lee JH, Shim YR, Kim MH,
Kim HH, Kim YE, Yang K, Kim K, Choi SE, et al: Metabotropic
glutamate receptor 5 in natural killer cells attenuates liver
fibrosis by exerting cytotoxicity to activated stellate cells.
Hepatology. 74:2170–2185. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Jin H, Jia Y, Yao Z, Huang J, Hao M, Yao
S, Lian N, Zhang F, Zhang C, Chen X, et al: Hepatic stellate cell
interferes with NK cell regulation of fibrogenesis via curcumin
induced senescence of hepatic stellate cell. Cell Signal. 33:79–85.
2017. View Article : Google Scholar
|
|
26
|
Gur C, Doron S, Kfir-Erenfeld S, Horwitz
E, Abu-Tair L, Safadi R and Mandelboim O: NKp46-mediated killing of
human and mouse hepatic stellate cells attenuates liver fibrosis.
Gut. 61:885–893. 2012. View Article : Google Scholar
|
|
27
|
Li W, Jiang Y, Wang X, Jin J, Qi Y, Chi X,
Zhang H, Feng X and Niu J: Natural killer p46 controls hepatitis B
virus replication and modulates liver inflammation. PLoS One.
10:e01358742015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Nattermann J, Feldmann G, Ahlenstiel G,
Langhans B, Sauerbruch T and Spengler U: Surface expression and
cytolytic function of natural killer cell receptors is altered in
chronic hepatitis C. Gut. 55:869–877. 2006. View Article : Google Scholar
|
|
29
|
Nel I, Lucar O, Petitdemange C, Béziat V,
Lapalus M, Bédossa P, Debré P, Asselah T, Marcellin P and Vieillard
V: Accumulation of intrahepatic TNF-α-producing NKp44+ NK cells
correlates with liver fibrosis and viral load in chronic HCV
infection. Medicine (Baltimore). 95:e36782016. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Wijaya RS, Read SA, Schibeci S, Eslam M,
Azardaryany MK, El-Khobar K, van der Poorten D, Lin R, Yuen L, Lam
V, et al: KLRG1+ natural killer cells exert a novel antifibrotic
function in chronic hepatitis B. J Hepatol. 71:252–264. 2019.
View Article : Google Scholar
|
|
31
|
Abu-Tair L, Axelrod JH, Doron S, Ovadya Y,
Krizhanovsky V, Galun E, Amer J and Safadi R: Natural killer
cell-dependent anti-fibrotic pathway in liver injury via Toll-like
receptor-9. PLoS One. 8:e825712013. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Cai X, Wang J, Wang J, Zhou Q, Yang B, He
Q and Weng Q: Intercellular crosstalk of hepatic stellate cells in
liver fibrosis: New insights into therapy. Pharmacol Res.
155:1047202020. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Muhanna N, Abu Tair L, Doron S, Amer J,
Azzeh M, Mahamid M, Friedman S and Safadi R: Amelioration of
hepatic fibrosis by NK cell activation. Gut. 60:90–98. 2011.
View Article : Google Scholar
|
|
34
|
Schölzel K, Schildberg FA, Welz M, Börner
C, Geiger S, Kurts C, Heikenwälder M, Knolle PA and Wohlleber D:
Transfer of MHC-class-I molecules among liver sinusoidal cells
facilitates hepatic immune surveillance. J Hepatol. 61:600–608.
2014. View Article : Google Scholar
|
|
35
|
Arriola Benitez PC, Pesce Viglietti AI,
Elizalde MM, Giambartolomei GH, Quarleri JF and Delpino MV: Hepatic
stellate cells and hepatocytes as liver Antigen-presenting cells
during B. abortus Infection. Pathogens. 9:5272020. View Article : Google Scholar
|
|
36
|
Chen Y, Lu D, Churov A and Fu R: Research
progress on NK cell receptors and their signaling pathways.
Mediators Inflamm. 2020:64370572020. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Radaeva S, Wang L, Radaev S, Jeong WI,
Park O and Gao B: Retinoic acid signaling sensitizes hepatic
stellate cells to NK cell killing via upregulation of NK cell
activating ligand RAE1. Am J Physiol Gastrointest Liver Physiol.
293:G809–G816. 2007. View Article : Google Scholar
|
|
38
|
Park O, Jeong WI, Wang L, Wang H, Lian ZX,
Gershwin ME and Gao B: Diverse roles of invariant natural killer T
cells in liver injury and fibrosis induced by carbon tetrachloride.
Hepatology. 49:1683–1694. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Fugier E, Marche H, Thelu MA, Macek
Jílková Z, Van Campenhout N, Dufeu-Duchesne T, Leroy V, Zarski JP,
Sturm N, Marche PN and Jouvin-Marche E: Functions of liver natural
killer cells are dependent on the severity of liver inflammation
and fibrosis in chronic hepatitis C. PLoS One. 9:e956142014.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Radaeva S, Sun R, Jaruga B, Nguyen VT,
Tian Z and Gao B: Natural killer cells ameliorate liver fibrosis by
killing activated stellate cells in NKG2D-dependent and tumor
necrosis factor-related apoptosis-inducing ligand-dependent
manners. Gastroenterology. 130:435–452. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Jeong WI, Park O, Radaeva S and Gao B:
STAT1 inhibits liver fibrosis in mice by inhibiting stellate cell
proliferation and stimulating NK cell cytotoxicity. Hepatology.
44:1441–1451. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Ma PF, Gao CC, Yi J, Zhao JL, Liang SQ,
Zhao Y, Ye YC, Bai J, Zheng QJ, Dou KF, et al: Cytotherapy with
M1-polarized macrophages ameliorates liver fibrosis by modulating
immune microenvironment in mice. J Hepatol. 67:770–779. 2017.
View Article : Google Scholar
|
|
43
|
Glassner A, Eisenhardt M, Kramer B, Körner
C, Coenen M, Sauerbruch T, Spengler U and Nattermann J: NK cells
from HCV-infected patients effectively induce apoptosis of
activated primary human hepatic stellate cells in a TRAIL-, FasL-
and NKG2D-dependent manner. Lab Invest. 92:967–977. 2012.
View Article : Google Scholar
|
|
44
|
Oh Y, Park O, Swierczewska M, Hamilton JP,
Park JS, Kim TH, Lim SM, Eom H, Jo DG, Lee CE, et al: Systemic
PEGylated TRAIL treatment ameliorates liver cirrhosis in rats by
eliminating activated hepatic stellate cells. Hepatology.
64:209–223. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Rockey DC, Maher JJ, Jarnagin WR, Gabbiani
G and Friedman SL: Inhibition of rat hepatic lipocyte activation in
culture by interferon-gamma. Hepatology. 16:776–784. 1992.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Hou X, Yu F, Man S, Huang D, Zhang Y, Liu
M, Ren C and Shen J: Negative regulation of Schistosoma japonicum
egg-induced liver fibrosis by natural killer cells. PLoS Negl Trop
Dis. 6:e14562012. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Parola M and Pinzani M: Liver fibrosis:
Pathophysiology, pathogenetic targets and clinical issues. Mol
Aspects Med. 65:37–55. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Zhang M, Serna-Salas S, Damba T, Borghesan
M, Demaria M and Moshage H: Hepatic stellate cell senescence in
liver fibrosis: Characteristics, mechanisms and perspectives. Mech
Ageing Dev. 199:1115722021. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Fan Y, Zhang W, Wei H, Sun R, Tian Z and
Chen Y: Hepatic NK cells attenuate fibrosis progression of
non-alcoholic steatohepatitis in dependent of CXCL10-mediated
recruitment. Liver Int. 40:598–608. 2020. View Article : Google Scholar
|
|
50
|
Wu Y, Min J, Ge C, Shu J, Tian D, Yuan Y
and Zhou D: Interleukin 22 in liver injury, inflammation and
cancer. Int J Biol Sci. 16:2405–2413. 2020. View Article : Google Scholar
|
|
51
|
Huang YH, Chen MH, Guo QL, Chen YX, Zhang
LJ, Chen ZX and Wang XZ: Interleukin-10 promotes primary rat
hepatic stellate cell senescence by upregulating the expression
levels of p53 and p21. Mol Med Rep. 17:5700–5707. 2018.PubMed/NCBI
|
|
52
|
Huang YH, Chen MH, Guo QL, Chen ZX, Chen
QD and Wang XZ: Interleukin-10 induces senescence of activated
hepatic stellate cells via STAT3-p53 pathway to attenuate liver
fibrosis. Cell Signal. 66:1094452020. View Article : Google Scholar
|
|
53
|
Kong X, Feng D, Wang H, Hong F, Bertola A,
Wang FS and Gao B: Interleukin-22 induces hepatic stellate cell
senescence and restricts liver fibrosis in mice. Hepatology.
56:1150–1159. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Chen J, Xu T, Zhu D, Wang J, Huang C, Lyu
L, Hu B, Sun W and Duan Y: Egg antigen p40 of Schistosoma japonicum
promotes senescence in activated hepatic stellate cells by
activation of the STAT3/p53/p21 pathway. Cell Death Dis.
7:e23152016. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Jin H, Lian N, Zhang F, Chen L, Chen Q, Lu
C, Bian M, Shao J, Wu L and Zheng S: Activation of PPARγ/P53
signaling is required for curcumin to induce hepatic stellate cell
senescence. Cell Death Dis. 7:e21892016. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Sagiv A, Biran A, Yon M, Simon J, Lowe SW
and Krizhanovsky V: Granule exocytosis mediates immune surveillance
of senescent cells. Oncogene. 32:1971–1977. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Muhanna N, Doron S, Wald O, Horani A, Eid
A, Pappo O, Friedman SL and Safadi R: Activation of hepatic
stellate cells after phagocytosis of lymphocytes: A novel pathway
of fibrogenesis. Hepatology. 48:963–977. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Shi J, Zhao J, Zhang X, Cheng Y, Hu J, Li
Y, Zhao X, Shang Q, Sun Y, Tu B, et al: Activated hepatic stellate
cells impair NK cell anti-fibrosis capacity through a
TGF-β-dependent emperipolesis in HBV cirrhotic patients. Sci Rep.
7:445442017. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Yu J, Wei M, Becknell B, Trotta R, Liu S,
Boyd Z, Jaung MS, Blaser BW, Sun J, Benson DM Jr, et al: Pro- and
antiinflammatory cytokine signaling: Reciprocal antagonism
regulates interferon-gamma production by human natural killer
cells. Immunity. 24:575–590. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Jeong WI, Park O and Gao B: Abrogation of
the antifibrotic effects of natural killer cells/interferon-gamma
contributes to alcohol acceleration of liver fibrosis.
Gastroenterology. 134:248–258. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Peppa D, Micco L, Javaid A, Kennedy PT,
Schurich A, Dunn C, Pallant C, Ellis G, Khanna P, Dusheiko G, et
al: Blockade of immunosuppressive cytokines restores NK cell
antiviral function in chronic hepatitis B virus infection. PLoS
Pathog. 6:e10012272010. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Dasgupta S, Bhattacharya-Chatterjee M,
O'Malley BW Jr and Chatterjee SK: Inhibition of NK cell activity
through TGF-beta 1 by down-regulation of NKG2D in a murine model of
head and neck cancer. J Immunol. 175:5541–5550. 2005. View Article : Google Scholar
|
|
63
|
Sene D, Levasseur F, Abel M, Lambert M,
Camous X, Hernandez C, Pène V, Rosenberg AR, Jouvin-Marche E,
Marche PN, et al: Hepatitis C virus (HCV) evades NKG2D-dependent NK
cell responses through NS5A-mediated imbalance of inflammatory
cytokines. PLoS Pathog. 6:e10011842010. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Sun C, Fu B, Gao Y, Liao X, Sun R, Tian Z
and Wei H: TGF-β1 down-regulation of NKG2D/DAP10 and 2B4/SAP
expression on human NK cells contributes to HBV persistence. PLoS
Pathog. 8:e10025942012. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Peng Y, Huang K, Shen L, Tao YY and Liu
CH: Cultured mycelium cordyceps sinensis alleviates CCl4-induced
liver inflammation and fibrosis in mice by activating hepatic
natural killer cells. Acta Pharmacol Sin. 37:204–216. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Peng Y, Yang T, Huang K, Shen L, Tao Y and
Liu C: Salvia miltiorrhiza ameliorates liver fibrosis by activating
hepatic natural killer cells in vivo and in vitro. Front Pharmacol.
9:7622018. View Article : Google Scholar
|
|
67
|
Xia Y, Yu B, Ma C, Tu Y, Zhai L, Yang Y,
Liu D, Liu Y, Wu H, Dan H and You P: Yu Gan Long reduces rat liver
fibrosis by blocking TGF-β 1/Smad pathway and modulating the
immunity. Biomed Pharmacother. 106:1332–1338. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
68
|
van Dijk F, Olinga P, Poelstra K and
Beljaars L: Targeted therapies in liver fibrosis: Combining the
best parts of Platelet-Derived growth factor BB and interferon
gamma. Front Med (Lausanne). 2:722015.PubMed/NCBI
|
|
69
|
Polo ML, Ghiglione YA, Salido JP, Urioste
A, Poblete G, Sisto AE, Martinez A, Rolón MJ, Ojeda DS, Cahn PE, et
al: Liver cirrhosis in HIV/HCV-coinfected individuals is related to
NK cell dysfunction and exhaustion, but not to an impaired NK cell
modulation by CD4+ T-cells. J Int AIDS Soc.
22:e253752019. View Article : Google Scholar
|
|
70
|
Li Y, Wang JJ, Gao S, Liu Q, Bai J, Zhao
XQ, Hao YH, Ding HH, Zhu F, Yang DL and Zhao XP: Decreased
peripheral natural killer cells activity in the immune activated
stage of chronic hepatitis B. PLoS One. 9:e869272014. View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Han QJ, Mu YL, Zhao HJ, Zhao RR, Guo QJ,
Su YH and Zhang J: Fasudil prevents liver fibrosis via activating
natural killer cells and suppressing hepatic stellate cells. World
J Gastroenterol. 27:3581–3594. 2021. View Article : Google Scholar
|
